ACUSHNET HOLDINGS CORP., 10-Q filed on 5/4/2023
Quarterly Report
v3.23.1
Cover Page - shares
3 Months Ended
Mar. 31, 2023
Apr. 28, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity File Number 001-37935  
Entity Registrant Name Acushnet Holdings Corp.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 45-2644353  
Entity Address, Address Line One 333 Bridge Street  
Entity Address, City or Town Fairhaven,  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02719  
City Area Code 800  
Local Phone Number 225-8500  
Title of 12(b) Security Common Stock - $0.001 par value per share  
Trading Symbol GOLF  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   67,363,140
Entity Central Index Key 0001672013  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash, cash equivalents and restricted cash ($15,970 and $14,376 attributable to the variable interest entity ("VIE")) $ 57,284 $ 58,904
Accounts receivable, net 435,385 216,695
Inventories ($8,238 and $17,866 attributable to the VIE) 639,123 674,684
Prepaid and other assets 134,455 108,793
Total current assets 1,266,247 1,059,076
Property, plant and equipment, net ($9,848 and $10,089 attributable to the VIE) 260,403 254,472
Goodwill ($32,312 and $32,312 attributable to the VIE) 225,352 224,814
Intangible assets, net 547,859 525,903
Deferred income taxes 34,444 47,551
Other assets ($2,060 and $2,083 attributable to the VIE) 118,708 81,991
Total assets 2,453,013 2,193,807
Current liabilities    
Short-term debt 44,555 40,336
Accounts payable ($7,888 and $11,914 attributable to the VIE) 161,300 166,998
Accrued taxes 72,077 40,922
Accrued compensation and benefits ($857 and $1,651 attributable to the VIE) 67,319 98,245
Accrued expenses and other liabilities ($2,385 and $3,380 attributable to the VIE) 119,076 202,124
Total current liabilities 464,327 548,625
Long-term debt 784,573 527,509
Deferred income taxes 5,746 5,896
Accrued pension and other postretirement benefits 75,298 74,234
Other noncurrent liabilities ($2,147 and $2,145 attributable to the VIE) 90,251 54,177
Total liabilities 1,420,195 1,210,441
Commitments and contingencies (Note 15)
Redeemable noncontrolling interests 7,670 6,663
Shareholders' equity    
Common stock, $0.001 par value, 500,000,000 shares authorized; 76,769,461 and 76,321,523 shares issued 77 76
Additional paid-in capital 956,834 960,685
Accumulated other comprehensive loss, net of tax (113,679) (109,668)
Retained earnings 552,596 473,130
Treasury stock, at cost; 9,406,503 and 8,892,425 shares (including 2,000,839 of accrued share repurchases as of December 31, 2022) (Note 10) (408,706) (385,167)
Total equity attributable to Acushnet Holdings Corp. 987,122 939,056
Noncontrolling interests 38,026 37,647
Total shareholders' equity 1,025,148 976,703
Total liabilities, redeemable noncontrolling interests and shareholders' equity $ 2,453,013 $ 2,193,807
v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Cash, cash equivalents and restricted cash $ 57,284 $ 58,904
Inventories 639,123 674,684
Property, plant and equipment, net 260,403 254,472
Goodwill 225,352 224,814
Other assets 118,708 81,991
Accounts payable 161,300 166,998
Accrued compensation and benefits 67,319 98,245
Accrued expenses and other liabilities 119,076 202,124
Other noncurrent liabilities $ 90,251 $ 54,177
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 76,769,461 76,321,523
Treasury stock, at cost (in shares) 9,406,503 8,892,425
Accrued share repurchases (in shares)   2,000,839
VIE    
Cash, cash equivalents and restricted cash $ 15,970 $ 14,376
Inventories 8,238 17,866
Property, plant and equipment, net 9,848 10,089
Goodwill 32,312 32,312
Other assets 2,060 2,083
Accounts payable 7,888 11,914
Accrued compensation and benefits 857 1,651
Accrued expenses and other liabilities 2,385 3,380
Other noncurrent liabilities $ 2,147 $ 2,145
v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Net sales $ 686,290 $ 606,087
Cost of goods sold 320,618 289,088
Gross profit 365,672 316,999
Operating expenses:    
Selling, general and administrative 222,539 195,691
Research and development 14,540 13,976
Intangible amortization 3,689 1,963
Income from operations 124,904 105,369
Interest expense, net 9,896 1,277
Other expense, net 664 1,326
Income before income taxes 114,344 102,766
Income tax expense 20,725 20,919
Net income 93,619 81,847
Less: Net income attributable to noncontrolling interests (344) (802)
Net income attributable to Acushnet Holdings Corp. $ 93,275 $ 81,045
Net income per common share attributable to Acushnet Holdings Corp.:    
Basic (in dollars per share) $ 1.37 $ 1.10
Diluted (in dollars per share) $ 1.36 $ 1.10
Weighted average number of common shares:    
Basic (in shares) 68,213,068 73,513,109
Diluted (in shares) 68,646,212 73,922,728
v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Comprehensive Income [Abstract]    
Net income $ 93,619 $ 81,847
Other comprehensive loss:    
Foreign currency translation adjustments 565 (7,570)
Cash flow derivative instruments:    
Unrealized holding (losses) gains arising during period (833) 3,076
Reclassification adjustments included in net income (5,211) (1,355)
Tax benefit (expense) 1,784 (516)
Cash flow derivative instruments, net (4,260) 1,205
Pension and other postretirement benefits:    
Pension and other postretirement benefits adjustments (406) 1,863
Tax benefit (expense) 90 (443)
Pension and other postretirement benefits adjustments, net (316) 1,420
Total other comprehensive loss (4,011) (4,945)
Comprehensive income 89,608 76,902
Less: Comprehensive income attributable to noncontrolling interests (408) (747)
Comprehensive income attributable to Acushnet Holdings Corp. $ 89,200 $ 76,155
v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities    
Net income $ 93,619 $ 81,847
Adjustments to reconcile net income to cash flows used in operating activities    
Depreciation and amortization 12,631 10,367
Unrealized foreign exchange (gain) loss (2,768) 1,433
Amortization of debt issuance costs 165 203
Share-based compensation 7,283 5,353
Gain on disposals of property, plant and equipment (6) (1)
Deferred income taxes 14,278 4,341
Changes in operating assets and liabilities    
Accounts receivable (218,544) (206,468)
Inventories 35,126 (39,341)
Accounts payable (4,833) 30,079
Accrued taxes 31,468 17,464
Other assets and liabilities (54,837) (69,325)
Cash flows used in operating activities (86,418) (164,048)
Cash flows from investing activities    
Additions to property, plant and equipment (11,698) (11,686)
Additions to intangible assets (Note 16) (22,235) 0
Other, net (901) 0
Cash flows used in investing activities (34,834) (11,686)
Cash flows from financing activities    
(Repayments of) proceeds from short-term borrowings, net (Note 5) (3,796) 97,700
Proceeds from revolving credit facilities (Note 5) 539,783 0
Repayments of revolving credit facilities (Note 5) (275,873) 0
Repayments of term loan facility (Note 5) 0 (4,375)
Purchases of common stock (116,123) (59,108)
Dividends paid on common stock (14,304) (13,984)
Dividends paid to noncontrolling interests 0 (101)
Payment of employee restricted stock tax withholdings (11,455) (10,661)
Other, net 1,078 0
Cash flows provided by financing activities 119,310 9,471
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash 322 (1,012)
Net decrease in cash, cash equivalents and restricted cash (1,620) (167,275)
Cash, cash equivalents and restricted cash, beginning of year 58,904 281,677
Cash, cash equivalents and restricted cash, end of period 57,284 114,402
Supplemental non-cash information    
Purchases of property, plant and equipment, accrued not paid 3,595 1,744
Additions to right-of-use assets obtained in exchange for operating lease obligations 41,894 8,065
Additions to right-of-use assets obtained in exchange for finance lease obligations 607 335
Dividend equivalents rights ("DERs") declared not paid 452 427
Contingent consideration (Note 16) $ 3,000 $ 0
v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders' Equity Attributable to Acushnet Holdings Corp.
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Tax
Retained Earnings
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2021     75,855          
Beginning balance at Dec. 31, 2021 $ 1,080,267 $ 1,042,844 $ 76 $ 948,423 $ (99,582) $ 324,966 $ (131,039) $ 37,423
Changes in stockholders' equity                
Net income 82,026 81,045       81,045   981
Other comprehensive loss (4,945) (4,945)     (4,945)      
Share-based compensation 5,189 5,189   5,189        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     434          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (10,373) (10,373)   (10,373)        
Purchases of common stock (Note 10) (29,894) (29,894)         (29,894)  
Dividends and dividend equivalents declared (13,473) (13,473)       (13,473)    
Dividends declared to noncontrolling interests (101)             (101)
Ending balance (in shares) at Mar. 31, 2022     76,289          
Ending balance at Mar. 31, 2022 1,108,696 1,070,393 $ 76 943,239 (104,527) 392,538 (160,933) 38,303
Beginning balance (in shares) at Dec. 31, 2021     75,855          
Beginning balance at Dec. 31, 2021 1,080,267 1,042,844 $ 76 948,423 (99,582) 324,966 (131,039) 37,423
Changes in stockholders' equity                
Dividends and dividend equivalents declared (53,051)              
Ending balance (in shares) at Dec. 31, 2022     76,322          
Ending balance at Dec. 31, 2022 976,703 939,056 $ 76 960,685 (109,668) 473,130 (385,167) 37,647
Changes in stockholders' equity                
Sale of equity to noncontrolling interests 264 264   444   (180)    
Net income 93,654 93,275       93,275   379
Other comprehensive loss (4,011) (4,011)     (4,011)      
Share-based compensation 7,119 7,119   7,119        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     447          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (11,413) (11,413) $ 1 (11,414)        
Purchases of common stock (Note 10) (23,539) (23,539)         (23,539)  
Dividends and dividend equivalents declared (13,629) (13,629)       (13,629)    
Ending balance (in shares) at Mar. 31, 2023     76,769          
Ending balance at Mar. 31, 2023 $ 1,025,148 $ 987,122 $ 77 $ 956,834 $ (113,679) $ 552,596 $ (408,706) $ 38,026
v3.23.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.
Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results to be expected for the full year ending December 31, 2023, nor were those of the comparable 2022 periods representative of those actually experienced for the full year ended December 31, 2022. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2022 included in its Annual Report on Form 10-K filed with the SEC on March 1, 2023.
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Variable Interest Entities
VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE.
The Company consolidates the accounts of Acushnet Lionscore Limited, a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of March 31, 2023 and December 31, 2022. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE.
Noncontrolling Interests and Redeemable Noncontrolling Interests
The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.
Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The Company initially records the redeemable noncontrolling interest at its acquisition date fair value. The carrying amount of the redeemable noncontrolling interest is subsequently adjusted to the greater amount of either the initial carrying amount, increased or decreased for the redeemable noncontrolling interest's share of comprehensive income (loss) or the redemption value, assuming the noncontrolling interest is redeemable at the balance sheet date. This adjustment is recognized through retained earnings and is not reflected in net income (loss) or comprehensive income (loss). The value attributable to redeemable noncontrolling interests and any related loans to minority shareholders, which are recorded as a reduction to redeemable noncontrolling interests, are presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders was $4.4 million as of both March 31, 2023 and December 31, 2022.
Cash, Cash Equivalents and Restricted Cash
Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. As of both March 31, 2023 and December 31, 2022, the amount of restricted cash included in cash, cash equivalents and restricted cash on the unaudited condensed consolidated balance sheets was $1.8 million.
Foreign Currency Transactions
Foreign currency transaction losses included in selling, general and administrative expenses were $1.3 million and $1.8 million for the three months ended March 31, 2023 and 2022, respectively.
Recently Adopted Accounting Standards
The Company considers the applicability and impact of all Accounting Standards Updates ("ASUs"). Management determined that recently issued ASUs are not expected to have a material impact on the Company's consolidated financial statements.
v3.23.1
Allowance for Doubtful Accounts
3 Months Ended
Mar. 31, 2023
Receivables [Abstract]  
Allowance for Doubtful Accounts Allowance for Doubtful Accounts
The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current and forecasted economic conditions, which could affect the collectability of the reported amounts. All of these factors have been considered in the estimate of expected credit losses for the periods presented.
The activity related to the allowance for doubtful accounts was as follows:
Three months ended March 31,
(in thousands)20232022
Balance at beginning of period$8,258 $5,980 
Bad debt expense254 922 
Amount of receivables written off (52)(44)
Foreign currency translation48 (72)
Balance at end of period$8,508 $6,786 
v3.23.1
Inventories
3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Inventories Inventories
The components of inventories were as follows: 
March 31,December 31,
(in thousands)20232022
Raw materials and supplies$150,635 $154,881 
Work-in-process28,862 29,689 
Finished goods459,626 490,114 
Inventories$639,123 $674,684 
v3.23.1
Product Warranty
3 Months Ended
Mar. 31, 2023
Product Warranties Disclosures [Abstract]  
Product Warranty Product Warranty
The Company has defined warranties generally ranging from one to two years. Products covered by the defined warranty policies primarily include all Titleist golf products, FootJoy golf shoes and FootJoy golf outerwear. These product warranties generally obligate the Company to pay for the cost of replacement products, including the cost of shipping replacement products to its customers. The estimated cost of satisfying future warranty claims is accrued at the time the sale is recorded. In estimating future warranty obligations, the Company considers various factors, including its warranty policies and practices, the historical frequency of claims and the cost to replace or repair products under warranty.
The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:
 Three months ended March 31,
(in thousands)20232022
Balance at beginning of period$3,951 $4,177 
Provision1,675 995 
Claims paid/costs incurred(1,229)(1,045)
Foreign currency translation(11)(36)
Balance at end of period$4,386 $4,091 
v3.23.1
Debt and Financing Arrangements
3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Debt and Financing Arrangements Debt and Financing Arrangements
Credit Facility
On August 2, 2022, the Company amended its credit agreement to, among other things, provide a $950.0 million multi-currency revolving credit facility and amend rates per annum at which borrowings in different denominations bear interest (the "Second Amended Credit Facility"). On August 2, 2022, proceeds from borrowings under the multi-currency revolving credit facility were used to, among other things, prepay in full the Company's then-outstanding term loans and refinance its outstanding borrowings under the revolving credit facility. Immediately prior to payment, the aggregate amounts outstanding related to the term loans and revolving credit facility were approximately $306.3 million and $72.6 million, respectively. The Second Amended Credit Facility matures on August 2, 2027, and as a result, the related borrowings have been classified as long-term debt, with the proceeds and repayments under the revolving credit facility presented on a gross basis in the consolidated statements of cash flows.
The credit agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on the Company's leverage and interest coverage ratios. The credit agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2023, the Company was in compliance with all covenants under its credit agreement.
As of March 31, 2023, there were $783.0 million in outstanding borrowings under the Company's multi-currency revolving credit facility with a weighted average interest rate of 5.87%. As of March 31, 2023, the Company had available borrowings under its multi-currency revolving credit facility of $158.8 million after giving effect to $8.2 million of outstanding letters of credit.
Other Short-Term Borrowings
The Company has certain unsecured local credit facilities available through its subsidiaries. Amounts outstanding under other short-term borrowings are presented in short-term debt in the consolidated balance sheets with the proceeds and repayments presented on a gross basis in the consolidated statements of cash flows when the original maturity exceeds 90 days. There were $44.6 million and $40.3 million in outstanding borrowings under the Company's local credit facilities as of March 31, 2023 and December 31, 2022, respectively. The weighted average interest rate applicable to the outstanding borrowings was 0.82% and 0.85% as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023, the Company had available borrowings remaining under these local credit facilities of $25.3 million.
Letters of Credit
As of March 31, 2023 and December 31, 2022, there were outstanding letters of credit related to agreements, including the Company's Second Amended Credit Facility, totaling $12.0 million and $10.0 million, respectively, of which $8.6 million and $7.3 million, respectively, was secured. These agreements provided a maximum commitment for letters of credit of $58.8 million as of March 31, 2023.
v3.23.1
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
The Company principally uses derivative financial instruments to reduce the impact of foreign currency fluctuations and interest rate variability on the Company's results of operations. The principal derivative financial instruments the Company enters into are foreign exchange forward contracts and interest rate swaps. The Company does not enter into derivative financial instrument contracts for trading or speculative purposes.
Foreign Exchange Derivative Instruments
Foreign exchange forward contracts are foreign exchange derivative instruments primarily used to reduce foreign currency risk related to transactions denominated in a currency other than functional currency. These instruments are designated as cash flow hedges. The periods of the foreign exchange forward contracts correspond to the periods of the hedged forecasted transactions, which do not exceed 24 months subsequent to the latest balance sheet date. The primary foreign exchange forward contracts pertain to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won and the euro. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts designated under hedge accounting as of March 31, 2023 and December 31, 2022 was $225.3 million and $242.4 million, respectively.
The Company also enters into foreign exchange forward contracts, which either do not qualify as hedging instruments or have not been designated as such, to reduce foreign currency transaction risk related to certain intercompany assets and liabilities denominated in a currency other than functional currency. These undesignated instruments are recorded at fair value as a derivative asset or liability with the corresponding change in fair value recognized in selling, general and administrative expenses. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts not designated under hedge accounting as of both March 31, 2023 and December 31, 2022 was $4.0 million. Selling, general and administrative expenses during the three months ended March 31, 2023 and 2022 included a gain of $0.1 million and $0.3 million, respectively, related to undesignated foreign exchange forward derivative instruments.
Interest Rate Derivative Instruments
From time to time, the Company enters into interest rate swap contracts to reduce interest rate risk related to floating rate debt. Under the contracts, the Company pays fixed and receives variable rate interest, in effect converting a portion of its floating rate debt to fixed rate debt. Interest rate swap contracts are accounted for as cash flow hedges. As of March 31, 2023, the notional value of the Company's outstanding interest rate swap contracts was $100.0 million. As of December 31, 2022, there were no interest rate swap contracts outstanding.
Impact on Financial Statements
The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:
(in thousands)March 31,December 31,
Balance Sheet LocationHedge Instrument Type20232022
Prepaid and other assetsForeign exchange forward$6,078 $7,393 
Interest rate swap344 — 
Other assetsForeign exchange forward87 1,341 
Accrued expenses and other liabilitiesForeign exchange forward3,817 4,710 
Interest rate swap17 — 
Other noncurrent liabilitiesForeign exchange forward505 344 
Interest rate swap699 — 
The hedge instrument gain (loss) recognized in accumulated other comprehensive loss, net of tax was as follows:
 Three months ended
 March 31,
(in thousands)20232022
Type of hedge  
Foreign exchange forward$(477)$3,076 
Interest rate swap (356)— 
 Total$(833)$3,076 
Gains and losses on derivative instruments designated as cash flow hedges are reclassified from accumulated other comprehensive loss, net of tax at the time the forecasted hedged transaction impacts the statements of operations or at the time the hedge is determined to be ineffective. Based on the current valuation, during the next 12 months the Company expects to reclassify a net gain of $2.4 million related to foreign exchange derivative instruments from accumulated other comprehensive loss, net of tax, into cost of goods sold and a net gain of $0.3 million related to interest rate derivative instruments from accumulated other comprehensive loss, net of tax, into interest expense, net. For further information related to amounts recognized in accumulated other comprehensive loss, net of tax, see Note 12.
The hedge instrument gain (loss) recognized on the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
 March 31,
(in thousands)20232022
Location of gain (loss) in statements of operations  
Foreign exchange forward:
Cost of goods sold$5,196 $1,355 
Selling, general and administrative (1)
210 675 
Total $5,406 $2,030 
Interest Rate Swap:
Interest expense, net$15 $— 
Total$15 $— 
_______________________________________________________________________________
(1)    Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges.
Credit Risk
The Company enters into derivative contracts with major financial institutions with investment grade credit ratings and is exposed to credit losses in the event of non-performance by these financial institutions. This credit risk is generally limited to the unrealized gains in the derivative contracts. However, the Company monitors the credit quality of these financial institutions, as well as its own credit quality, and considers the risk of counterparty default to be minimal.
v3.23.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2023 were as follows:
 Fair Value Measurements as of 
 March 31, 2023 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$4,135 $— $— Prepaid and other assets
Foreign exchange derivative instruments— 6,098 — Prepaid and other assets
Interest rate derivative instruments— 344 — Other current assets
Deferred compensation program assets670 — — Other assets
Foreign exchange derivative instruments— 87 — Other assets
Total assets$4,805 $6,529 $—  
Liabilities    
Foreign exchange derivative instruments$— $3,817 $— Accrued expenses and other liabilities
Interest rate derivative instruments— 17 — Accrued expenses and other liabilities
Deferred compensation program liabilities670 — — Other noncurrent liabilities
Foreign exchange derivative instruments— 505 — Other noncurrent liabilities
Interest rate derivative instruments— 699 — Other noncurrent liabilities
Total liabilities$670 $5,038 $—  
Assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 were as follows:
 Fair Value Measurements as of 
 December 31, 2022 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$3,940 $— $— Prepaid and other assets
Foreign exchange derivative instruments— 7,393 — Prepaid and other assets
Deferred compensation program assets631 — — Other assets
Foreign exchange derivative instruments— 1,341 — Other assets
Total assets$4,571 $8,734 $—  
Liabilities    
Foreign exchange derivative instruments$— $4,758 $— Accrued expenses and other liabilities
Deferred compensation program liabilities631 — — Other noncurrent liabilities
Foreign exchange derivative instruments— 344 — Other noncurrent liabilities
Total liabilities$631 $5,102 $—  
Rabbi trust assets are used to fund certain retirement obligations of the Company. The assets underlying the Rabbi trust are equity and fixed income exchange-traded funds.
Deferred compensation program assets and liabilities represent a program where select employees could defer compensation until termination of employment. Effective July 29, 2011, this program was amended to cease all employee compensation deferrals and provided for the distribution of all previously deferred employee compensation. The program remains in effect with respect to the value attributable to the employer match contributed prior to July 29, 2011.
Foreign exchange derivative instruments are foreign exchange forward contracts primarily used to limit currency risk that would otherwise result from changes in foreign exchange rates (Note 6). The Company uses the mid-price of foreign exchange forward rates as of the close of business on the valuation date to value each foreign exchange forward contract at each reporting period.
Interest rate derivative instruments are interest rate swap contracts used to reduce interest rate risk related to the Company's floating rate debt (Note 6). The valuation for the interest rate swap is calculated as the net of the discounted future
cash flows of the pay and receive legs of the swap. Mid-market interest rates on the valuation date are used to create the forward curve for floating legs and discount curve.
v3.23.1
Pension and Other Postretirement Benefits
3 Months Ended
Mar. 31, 2023
Retirement Benefits [Abstract]  
Pension and Other Postretirement Benefits Pension and Other Postretirement Benefits
Components of net periodic benefit cost were as follows: 
 Pension BenefitsPostretirement Benefits
 Three months ended March 31,
(in thousands)2023202220232022
Components of net periodic benefit cost    
Service cost$1,434 $2,007 $119 $160 
Interest cost2,943 2,234 172 84 
Expected return on plan assets(1,962)(1,871)— — 
Amortization of net loss (gain)21 935 (201)(152)
Amortization of prior service cost (credit)46 69 (34)(34)
Net periodic benefit cost$2,482 $3,374 $56 $58 
The non-service cost components of net periodic benefit cost are included in other expense, net in the unaudited condensed consolidated statements of operations.
v3.23.1
Income Taxes
3 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income TaxesIncome tax expense decreased by $0.2 million to $20.7 million for the three months ended March 31, 2023 compared to $20.9 million for the three months ended March 31, 2022. The Company’s effective income tax rate ("ETR") was 18.1% for the three months ended March 31, 2023 compared to 20.4% for the three months ended March 31, 2022.The ETR for the three months ended March 31, 2023 differed from the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits, partially offset by the U.S. taxation of foreign income, state income taxes and the Company's geographic mix of income earned by the Company's international subsidiaries. The ETR for the three months ended March 31, 2022 differed from the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits, partially offset by the U.S. taxation of foreign income and the Company's geographic mix of income earned by its international subsidiaries
v3.23.1
Common Stock
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Common Stock Common Stock
Dividends
The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:
Dividends per Common Share
Amount
(in thousands)
2023:
First Quarter$0.195 $13,629 
Total dividends declared in 2023$0.195 $13,629 
2022:
Fourth Quarter$0.180 $12,986 
Third Quarter0.180 13,192 
Second Quarter0.180 13,400 
First Quarter0.180 13,473 
Total dividends declared in 2022$0.720 $53,051 
During the second quarter of 2023, the Company's Board of Directors declared a dividend of $0.195 per share of common stock to shareholders of record as of June 2, 2023 and payable on June 16, 2023.
Share Repurchase Program
As of March 31, 2023, the Board of Directors had authorized the Company to repurchase up to $700.0 million of its issued and outstanding common stock. Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at the discretion of the Company consistent with the Company's general working capital needs and within the constraints of the Company’s credit agreement.
On November 8, 2021, the Company entered into an agreement with Magnus Holdings Co., Ltd. (“Magnus”), a wholly-owned subsidiary of Fila Holdings Corp., to purchase from Magnus an equal amount of its common stock as it purchases on the open market, up to an aggregate of $37.5 million, at the same weighted average per share price (the "2021 Agreement"). In relation to the 2021 Agreement, on January 24, 2022, the Company purchased 699,819 shares of its common stock for an aggregate of $37.5 million from Magnus, in satisfaction of its obligations under the 2021 Agreement.
On June 16, 2022, the Company entered into an agreement with Magnus to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from July 1, 2022 through January 13, 2023, up to an aggregate of $75.0 million, at the same weighted average per share price (the "2022 Agreement"). On August 30, 2022, the Company amended and restated the 2022 Agreement to increase the aggregate dollar amount of shares of its common stock that it will purchase from Magnus from $75.0 million to $100.0 million, (the "Amended and Restated 2022 Agreement"). In relation to this agreement, the Company recorded a share repurchase liability of $92.6 million for 2,000,839 shares of common stock, which was included in accrued expenses and other liabilities and treasury stock on the consolidated balance sheet as of December 31, 2022. Between January 1, 2023 and January 13, 2023, the Company purchased an additional 167,689 shares of its common stock on the open market for an aggregate of $7.4 million, bringing the cumulative total open market purchases since the inception of the 2022 Agreement to $100.0 million. As a result, on January 23, 2023, the Company purchased 2,168,528 shares of its common stock from Magnus for an aggregate of $100.0 million, in satisfaction of its obligation under the Amended and Restated 2022 Agreement.
The Company's share repurchase activity for the periods presented was as follows:
Three months ended March 31,
(in thousands, except share and per share amounts)20232022
Shares repurchased in the open market:
Shares repurchased 346,389 463,980 
Average price$46.54 $46.57 
Aggregate value $16,122 $21,607 
Shares repurchased from Magnus:
Shares repurchased2,168,528 699,819 
Average price (1)
$46.11 $53.59 
Aggregate value$100,001 $37,501 
Total shares repurchased:
Shares repurchased2,514,917 1,163,799 
Average price$46.17 $50.79 
Aggregate value$116,123 $59,108 
___________________________________
(1)    In accordance with the share repurchase agreements, shares purchased from Magnus are accrued for at the same weighted average price as those purchased on the open market, as if the purchase from Magnus had occurred on the same day. As such, the average price of Magnus repurchases during the current period will differ from open market repurchases due to the settlement of the previously recorded share repurchase liability, as well as, open market purchases made after the completion of the Magnus Share repurchase agreements.
As of March 31, 2023, the Company had $291.3 million remaining under the current share repurchase authorization. This program will remain in effect until completed or until terminated by the Board of Directors.
v3.23.1
Equity Incentive Plans
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans Equity Incentive Plans
Under the Acushnet Holdings Corp. 2015 Omnibus Incentive Plan (“2015 Plan”), the Company may grant stock options, stock appreciation rights, restricted shares of common stock, restricted stock units ("RSUs"), performance stock units ("PSUs") and other share-based and cash-based awards to members of the Board of Directors, officers, employees, consultants and advisors of the Company. As of March 31, 2023, the only awards granted under the 2015 Plan were RSUs and PSUs.
Restricted Stock and Performance Stock Units
RSUs granted to members of the Board of Directors vest immediately into shares of common stock. RSUs granted to Company officers generally vest over three years, with one-third of each grant vesting annually, subject to the recipient's continued employment with the Company. RSUs granted to other employees, consultants and advisors of the Company vest in accordance with the terms of the grants, generally either over three years or, beginning in 2022, with one-third of each grant vesting annually, subject to the recipient’s continued service to the Company. PSUs granted to Company officers and other employees vest based upon the Company's performance against specified metrics, generally over a three-year performance period, subject to the recipient's continued service to the Company. At the end of the performance period, the number of shares of common stock that could be issued is determined based upon the Company's performance against these metrics. The number of shares that could be issued can range from 0% to 200% of the recipient's target award. Recipients of the awards granted under the 2015 Plan may elect to defer receipt of all or any portion of any shares of common stock issuable upon vesting to a future date elected by the recipient.
All RSUs and PSUs granted under the 2015 Plan have DERs, which entitle holders of RSUs and PSUs to the same dividend value per share as holders of common stock and can be paid in either cash or common stock. DERs are subject to the same vesting and other terms and conditions as the corresponding unvested RSUs and PSUs. DERs are paid when the underlying shares of common stock are delivered.
A summary of the Company’s RSUs and PSUs as of March 31, 2023 and changes during the three months then ended is presented below: 
 Weighted-Weighted-
 NumberAverageNumberAverage
 of RSUsFair Value RSUs
of PSUs (3)
Fair Value PSUs
Outstanding as of December 31, 2022944,695 $37.48 529,366 $36.30 
Granted337,567 48.58 168,251 48.58 
Vested (1)(2)
(499,896)31.04 (231,127)25.73 
Forfeited(4,179)43.87 (12,377)41.78 
Outstanding as of March 31, 2023778,187 $46.40 454,113 $46.08 

_______________________________________________________________________________
(1)    Includes 75,157 shares of common stock related to RSU's that were not delivered as of March 31, 2023.
(2)    Based upon the Company’s level of achievement of the applicable performance metrics, the recipients of the 231,127 PSUs that vested during the three months ended March 31, 2023, were entitled to receive 460,684 shares of common stock. As of March 31, 2023, there were 229,205 shares of common stock that had not been delivered in connection with the vesting of these PSUs.
(3)    Number of PSUs assume that 100% of the target level of performance was achieved
Compensation expense recorded related to RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20232022
RSUs$4,154 $2,770 
PSUs2,965 2,419 
The remaining unrecognized compensation expense related to unvested RSUs and unvested PSUs was $27.7 million and $15.0 million, respectively, as of March 31, 2023, and is expected to be recognized over the related weighted average period of 1.6 years and 2.2 years, respectively.
A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below:
Three months endedThree months ended
 March 31, 2023March 31, 2022
RSUsPSUsRSUsPSUs
Shares of common stock issued436,491 231,580 492,580 188,527 
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations
(128,291)(91,842)(159,851)(87,215)
Net shares of common stock issued308,200 139,738 332,729 101,312 
Cumulative undelivered shares of common stock471,306 420,447 414,866 191,242 
Compensation Expense
The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20232022
Cost of goods sold$373 $300 
Selling, general and administrative6,223 4,698 
Research and development687 355 
Total compensation expense before income tax7,283 5,353 
Income tax benefit1,492 1,176 
Total compensation expense, net of income tax$5,791 $4,177 
v3.23.1
Accumulated Other Comprehensive Loss, Net of Tax
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Accumulated Other Comprehensive Loss, Net of Tax Accumulated Other Comprehensive Loss, Net of Tax
Accumulated other comprehensive loss, net of tax consists of foreign currency translation adjustments, unrealized gains and losses from derivative instruments designated as cash flow hedges (Note 6) and pension and other postretirement adjustments (Note 8).
The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows:
 ForeignInterestAccumulated
 ForeignExchangeRate SwapPension andOther
CurrencyDerivativeDerivativeOtherComprehensive
(in thousands)TranslationInstrumentsInstrumentsPostretirementLoss, Net of Tax
Balance as of December 31, 2022$(97,855)$5,598 $— $(17,411)$(109,668)
Other comprehensive (loss) income before reclassifications565 (477)(356)(238)(506)
Amounts reclassified from accumulated other comprehensive loss, net of tax— (5,196)(15)(168)(5,379)
Tax expense— 1,694 90 90 1,874 
Balance as of March 31, 2023$(97,290)$1,619 $(281)$(17,727)$(113,679)
v3.23.1
Net Income per Common Share
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Net Income per Common Share Net Income per Common Share
The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:
 Three months ended
 March 31,
(in thousands, except share and per share amounts)20232022
Net income attributable to Acushnet Holdings Corp.$93,275 $81,045 
Weighted average number of common shares:
Basic68,213,068 73,513,109 
RSUs340,101 325,550 
PSUs93,043 84,069 
Diluted68,646,212 73,922,728 
Net income per common share attributable to Acushnet Holdings Corp.:
Basic$1.37 $1.10 
Diluted$1.36 $1.10 
Net income per common share attributable to Acushnet Holdings Corp. was calculated using the treasury stock method.
The Company’s potential dilutive securities for the three months ended March 31, 2023 and 2022 include RSUs and PSUs. PSUs vest based upon achievement of performance targets and are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the applicable reporting period regardless of whether such performance targets are probable of achievement. During both the first quarter of 2023 and 2022, the minimum performance target was achieved relating to certain PSUs and as a result, these PSUs have been included in diluted shares outstanding for the three months ended March 31, 2023 and 2022.
The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:
 Three months ended
 March 31,
 20232022
RSUs259,496 66,405 
v3.23.1
Segment Information
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company’s operating segments are based on how the Chief Operating Decision Maker (“CODM”) makes decisions about assessing performance and allocating resources. The Company has four reportable segments that are organized on the basis of product categories. These segments include Titleist golf balls, Titleist golf clubs, Titleist golf gear and FootJoy golf wear.
The CODM primarily evaluates performance using segment operating income (loss). Segment operating income (loss) includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the reportable segments, but excludes interest expense, net, restructuring charges, the non-service cost component of net periodic benefit cost, transaction fees and other non-operating gains and losses as the Company does not allocate these to the reportable segments. The CODM does not evaluate a measure of assets when assessing performance.
Results shown for the three months ended March 31, 2023 and 2022 are not necessarily those which would be achieved if each segment was an unaffiliated business enterprise. There are no intersegment transactions.
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31,
(in thousands)20232022
Net sales  
Titleist golf balls$192,001 $163,838 
Titleist golf clubs180,781 160,815 
Titleist golf gear67,043 44,146 
FootJoy golf wear205,274 197,553 
Other41,191 39,735 
Total net sales$686,290 $606,087 
Segment operating income  
Titleist golf balls$38,621 $33,373 
Titleist golf clubs40,545 32,228 
Titleist golf gear12,190 2,194 
FootJoy golf wear30,801 31,315 
Other6,564 7,427 
Total segment operating income128,721 106,537 
Reconciling items:  
Interest expense, net(9,896)(1,277)
Non-service cost component of net periodic benefit cost(985)(1,265)
Other(3,496)(1,229)
Total income before income tax$114,344 $102,766 
Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates.
Three months ended March 31,
(in thousands)20232022
United States$369,931 $295,126 
EMEA (1)
104,760 112,357 
Japan46,375 45,795 
Korea88,984 85,717 
Rest of World76,240 67,092 
Total net sales$686,290 $606,087 
_______________________________________________________________________________
(1) Europe, the Middle East and Africa ("EMEA")
v3.23.1
Commitments and Contingencies
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Obligations
During the normal course of its business, the Company enters into agreements to purchase goods and services, including purchase commitments for advertising (including media placement and production costs), finished goods inventory, capital expenditures and endorsement arrangements with professional golfers.
The Company's purchase obligations as of March 31, 2023 were as follows:
 Payments Due by Period
 Remainder of     
(in thousands)20232024202520262027Thereafter
Purchase obligations (1)
$245,899 $27,389 $7,133 $2,722 $2,430 $9,653 
_______________________________________________________________________________
(1)    The reported amounts exclude those liabilities included on the unaudited condensed consolidated balance sheet as of March 31, 2023.
Litigation
The Company and its subsidiaries are party to lawsuits associated with the normal conduct of their businesses and operations. It is not possible to predict the outcome of the pending actions, and, as with any litigation, it is possible that some of these actions could be decided unfavorably. Consequently, the Company is unable to estimate the ultimate aggregate amount of monetary loss, amounts covered by insurance or the financial impact that will result from such matters and has not recorded a liability related to potential losses.
v3.23.1
Other Business Developments
3 Months Ended
Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Other Business Developments Other Business Developments
In January 2023, the Company acquired certain trademarks from Club Glove, an industry leader specializing in premium performance golf travel products, for $25.2 million including cash consideration of $22.2 million and contingent consideration of $3.0 million, which was included in accrued expenses and other liabilities on the unaudited condensed consolidated balance sheet as of March 31, 2023. The trademarks acquired were included in the Company's Titleist golf gear reporting segment and will be amortized over a weighted average life of 10 years.
On November 4, 2022, the Company completed the acquisition of an 80% interest in certain assets and liabilities of TPI EDU, LLC, Onbase University, LP and Racquetfit, LP, (together known as "TPI") for cash consideration of $18.4 million. As part of the acquisition, the Company recorded a redeemable noncontrolling interest of $4.6 million (Note 1). TPI is a leading supplier of online courses, certifications, educational programs, live seminars, and other educational services in the golf, baseball and tennis industries. The results of TPI have been included in the Company's Titleist golf clubs reporting segment since the date of acquisition (Note 14).
On April 1, 2022, the Company acquired the outstanding equity interest in PG Golf LLC for $5.0 million, including cash consideration of $3.6 million and contingent consideration of $1.4 million, which was included in other noncurrent liabilities on the unaudited condensed consolidated balance sheet as of March 31, 2023 and December 31, 2022.
v3.23.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”) and include the accounts of Acushnet Holdings Corp. (the “Company”), its wholly-owned subsidiaries and less than wholly-owned subsidiaries, including a variable interest entity (“VIE”) in which the Company is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation.
Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results to be expected for the full year ending December 31, 2023, nor were those of the comparable 2022 periods representative of those actually experienced for the full year ended December 31, 2022. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2022 included in its Annual Report on Form 10-K filed with the SEC on March 1, 2023.
Use of Estimates
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Variable Interest Entities
Variable Interest Entities
VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE.
The Company consolidates the accounts of Acushnet Lionscore Limited, a VIE which is 40% owned by the Company. The sole purpose of the VIE is to manufacture the Company’s golf footwear and as such, the Company is deemed to be the primary beneficiary. The Company has presented separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of its consolidated VIE that can only be used to settle specific obligations of its consolidated VIE and the liabilities of its consolidated VIE for which creditors do not have recourse to its general credit. The general creditors of the VIE do not have recourse to the Company. Certain directors of the VIE have guaranteed the credit lines of the VIE, for which there were no outstanding borrowings as of March 31, 2023 and December 31, 2022. In addition, pursuant to the terms of the agreement governing the VIE, the Company is not required to provide financial support to the VIE.
Noncontrolling Interests and Redeemable Noncontrolling Interests
Noncontrolling Interests and Redeemable Noncontrolling Interests
The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.
Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The Company initially records the redeemable noncontrolling interest at its acquisition date fair value. The carrying amount of the redeemable noncontrolling interest is subsequently adjusted to the greater amount of either the initial carrying amount, increased or decreased for the redeemable noncontrolling interest's share of comprehensive income (loss) or the redemption value, assuming the noncontrolling interest is redeemable at the balance sheet date. This adjustment is recognized through retained earnings and is not reflected in net income (loss) or comprehensive income (loss). The value attributable to redeemable noncontrolling interests and any related loans to minority shareholders, which are recorded as a reduction to redeemable noncontrolling interests, are presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity.
Cash, Cash Equivalents and Restricted Cash Cash, Cash Equivalents and Restricted CashCash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations.
Foreign Currency Transactions
Foreign Currency Transactions
Foreign currency transaction losses included in selling, general and administrative expenses were $1.3 million and $1.8 million for the three months ended March 31, 2023 and 2022, respectively.
Recently Adopted Accounting Standards
Recently Adopted Accounting Standards
The Company considers the applicability and impact of all Accounting Standards Updates ("ASUs"). Management determined that recently issued ASUs are not expected to have a material impact on the Company's consolidated financial statements.
v3.23.1
Allowance for Doubtful Accounts (Tables)
3 Months Ended
Mar. 31, 2023
Receivables [Abstract]  
Schedule of Activity Related to the Allowance for Doubtful Accounts
The activity related to the allowance for doubtful accounts was as follows:
Three months ended March 31,
(in thousands)20232022
Balance at beginning of period$8,258 $5,980 
Bad debt expense254 922 
Amount of receivables written off (52)(44)
Foreign currency translation48 (72)
Balance at end of period$8,508 $6,786 
v3.23.1
Inventories (Tables)
3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Schedule of Inventories
The components of inventories were as follows: 
March 31,December 31,
(in thousands)20232022
Raw materials and supplies$150,635 $154,881 
Work-in-process28,862 29,689 
Finished goods459,626 490,114 
Inventories$639,123 $674,684 
v3.23.1
Product Warranty (Tables)
3 Months Ended
Mar. 31, 2023
Product Warranties Disclosures [Abstract]  
Schedule of Warranty Obligation for Accrued Warranty Expense
The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:
 Three months ended March 31,
(in thousands)20232022
Balance at beginning of period$3,951 $4,177 
Provision1,675 995 
Claims paid/costs incurred(1,229)(1,045)
Foreign currency translation(11)(36)
Balance at end of period$4,386 $4,091 
v3.23.1
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets
The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:
(in thousands)March 31,December 31,
Balance Sheet LocationHedge Instrument Type20232022
Prepaid and other assetsForeign exchange forward$6,078 $7,393 
Interest rate swap344 — 
Other assetsForeign exchange forward87 1,341 
Accrued expenses and other liabilitiesForeign exchange forward3,817 4,710 
Interest rate swap17 — 
Other noncurrent liabilitiesForeign exchange forward505 344 
Interest rate swap699 — 
Schedule of Effect of Hedge Instruments on Accumulated Other Comprehensive Loss, Net of Tax
The hedge instrument gain (loss) recognized in accumulated other comprehensive loss, net of tax was as follows:
 Three months ended
 March 31,
(in thousands)20232022
Type of hedge  
Foreign exchange forward$(477)$3,076 
Interest rate swap (356)— 
 Total$(833)$3,076 
Schedule of Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations
The hedge instrument gain (loss) recognized on the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
 March 31,
(in thousands)20232022
Location of gain (loss) in statements of operations  
Foreign exchange forward:
Cost of goods sold$5,196 $1,355 
Selling, general and administrative (1)
210 675 
Total $5,406 $2,030 
Interest Rate Swap:
Interest expense, net$15 $— 
Total$15 $— 
_______________________________________________________________________________
(1)    Relates to net gains (losses) on foreign exchange forward contracts derived from previously designated cash flow hedges.
v3.23.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2023 were as follows:
 Fair Value Measurements as of 
 March 31, 2023 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$4,135 $— $— Prepaid and other assets
Foreign exchange derivative instruments— 6,098 — Prepaid and other assets
Interest rate derivative instruments— 344 — Other current assets
Deferred compensation program assets670 — — Other assets
Foreign exchange derivative instruments— 87 — Other assets
Total assets$4,805 $6,529 $—  
Liabilities    
Foreign exchange derivative instruments$— $3,817 $— Accrued expenses and other liabilities
Interest rate derivative instruments— 17 — Accrued expenses and other liabilities
Deferred compensation program liabilities670 — — Other noncurrent liabilities
Foreign exchange derivative instruments— 505 — Other noncurrent liabilities
Interest rate derivative instruments— 699 — Other noncurrent liabilities
Total liabilities$670 $5,038 $—  
Assets and liabilities measured at fair value on a recurring basis as of December 31, 2022 were as follows:
 Fair Value Measurements as of 
 December 31, 2022 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$3,940 $— $— Prepaid and other assets
Foreign exchange derivative instruments— 7,393 — Prepaid and other assets
Deferred compensation program assets631 — — Other assets
Foreign exchange derivative instruments— 1,341 — Other assets
Total assets$4,571 $8,734 $—  
Liabilities    
Foreign exchange derivative instruments$— $4,758 $— Accrued expenses and other liabilities
Deferred compensation program liabilities631 — — Other noncurrent liabilities
Foreign exchange derivative instruments— 344 — Other noncurrent liabilities
Total liabilities$631 $5,102 $—  
v3.23.1
Pension and Other Postretirement Benefits (Tables)
3 Months Ended
Mar. 31, 2023
Retirement Benefits [Abstract]  
Schedule of Components of Net Periodic Benefit Cost
Components of net periodic benefit cost were as follows: 
 Pension BenefitsPostretirement Benefits
 Three months ended March 31,
(in thousands)2023202220232022
Components of net periodic benefit cost    
Service cost$1,434 $2,007 $119 $160 
Interest cost2,943 2,234 172 84 
Expected return on plan assets(1,962)(1,871)— — 
Amortization of net loss (gain)21 935 (201)(152)
Amortization of prior service cost (credit)46 69 (34)(34)
Net periodic benefit cost$2,482 $3,374 $56 $58 
v3.23.1
Common Stock (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of Declared Dividends Per Share
The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:
Dividends per Common Share
Amount
(in thousands)
2023:
First Quarter$0.195 $13,629 
Total dividends declared in 2023$0.195 $13,629 
2022:
Fourth Quarter$0.180 $12,986 
Third Quarter0.180 13,192 
Second Quarter0.180 13,400 
First Quarter0.180 13,473 
Total dividends declared in 2022$0.720 $53,051 
Schedule of Share Repurchase Activity
The Company's share repurchase activity for the periods presented was as follows:
Three months ended March 31,
(in thousands, except share and per share amounts)20232022
Shares repurchased in the open market:
Shares repurchased 346,389 463,980 
Average price$46.54 $46.57 
Aggregate value $16,122 $21,607 
Shares repurchased from Magnus:
Shares repurchased2,168,528 699,819 
Average price (1)
$46.11 $53.59 
Aggregate value$100,001 $37,501 
Total shares repurchased:
Shares repurchased2,514,917 1,163,799 
Average price$46.17 $50.79 
Aggregate value$116,123 $59,108 
___________________________________
(1)    In accordance with the share repurchase agreements, shares purchased from Magnus are accrued for at the same weighted average price as those purchased on the open market, as if the purchase from Magnus had occurred on the same day. As such, the average price of Magnus repurchases during the current period will differ from open market repurchases due to the settlement of the previously recorded share repurchase liability, as well as, open market purchases made after the completion of the Magnus Share repurchase agreements.
v3.23.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted and Performance Stock Units
A summary of the Company’s RSUs and PSUs as of March 31, 2023 and changes during the three months then ended is presented below: 
 Weighted-Weighted-
 NumberAverageNumberAverage
 of RSUsFair Value RSUs
of PSUs (3)
Fair Value PSUs
Outstanding as of December 31, 2022944,695 $37.48 529,366 $36.30 
Granted337,567 48.58 168,251 48.58 
Vested (1)(2)
(499,896)31.04 (231,127)25.73 
Forfeited(4,179)43.87 (12,377)41.78 
Outstanding as of March 31, 2023778,187 $46.40 454,113 $46.08 

_______________________________________________________________________________
(1)    Includes 75,157 shares of common stock related to RSU's that were not delivered as of March 31, 2023.
(2)    Based upon the Company’s level of achievement of the applicable performance metrics, the recipients of the 231,127 PSUs that vested during the three months ended March 31, 2023, were entitled to receive 460,684 shares of common stock. As of March 31, 2023, there were 229,205 shares of common stock that had not been delivered in connection with the vesting of these PSUs.
(3)    Number of PSUs assume that 100% of the target level of performance was achieved
Schedule of Compensation Expense Recorded in the Consolidated Statement of Operations
Compensation expense recorded related to RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20232022
RSUs$4,154 $2,770 
PSUs2,965 2,419 
Schedule of Shares of Common Stock Issued
A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below:
Three months endedThree months ended
 March 31, 2023March 31, 2022
RSUsPSUsRSUsPSUs
Shares of common stock issued436,491 231,580 492,580 188,527 
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations
(128,291)(91,842)(159,851)(87,215)
Net shares of common stock issued308,200 139,738 332,729 101,312 
Cumulative undelivered shares of common stock471,306 420,447 414,866 191,242 
Schedule of Compensation Expense Related to Equity Incentive Plans
The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20232022
Cost of goods sold$373 $300 
Selling, general and administrative6,223 4,698 
Research and development687 355 
Total compensation expense before income tax7,283 5,353 
Income tax benefit1,492 1,176 
Total compensation expense, net of income tax$5,791 $4,177 
v3.23.1
Accumulated Other Comprehensive Loss, Net of Tax (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Schedule of Changes in Each Component of Accumulated Comprehensive Loss, Net of Tax Effects
The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows:
 ForeignInterestAccumulated
 ForeignExchangeRate SwapPension andOther
CurrencyDerivativeDerivativeOtherComprehensive
(in thousands)TranslationInstrumentsInstrumentsPostretirementLoss, Net of Tax
Balance as of December 31, 2022$(97,855)$5,598 $— $(17,411)$(109,668)
Other comprehensive (loss) income before reclassifications565 (477)(356)(238)(506)
Amounts reclassified from accumulated other comprehensive loss, net of tax— (5,196)(15)(168)(5,379)
Tax expense— 1,694 90 90 1,874 
Balance as of March 31, 2023$(97,290)$1,619 $(281)$(17,727)$(113,679)
v3.23.1
Net Income per Common Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Income Per Common Share
The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:
 Three months ended
 March 31,
(in thousands, except share and per share amounts)20232022
Net income attributable to Acushnet Holdings Corp.$93,275 $81,045 
Weighted average number of common shares:
Basic68,213,068 73,513,109 
RSUs340,101 325,550 
PSUs93,043 84,069 
Diluted68,646,212 73,922,728 
Net income per common share attributable to Acushnet Holdings Corp.:
Basic$1.37 $1.10 
Diluted$1.36 $1.10 
Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares
The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:
 Three months ended
 March 31,
 20232022
RSUs259,496 66,405 
v3.23.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Schedule of Information by Reportable Segment and a Reconciliation to Reported Amounts
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31,
(in thousands)20232022
Net sales  
Titleist golf balls$192,001 $163,838 
Titleist golf clubs180,781 160,815 
Titleist golf gear67,043 44,146 
FootJoy golf wear205,274 197,553 
Other41,191 39,735 
Total net sales$686,290 $606,087 
Segment operating income  
Titleist golf balls$38,621 $33,373 
Titleist golf clubs40,545 32,228 
Titleist golf gear12,190 2,194 
FootJoy golf wear30,801 31,315 
Other6,564 7,427 
Total segment operating income128,721 106,537 
Reconciling items:  
Interest expense, net(9,896)(1,277)
Non-service cost component of net periodic benefit cost(985)(1,265)
Other(3,496)(1,229)
Total income before income tax$114,344 $102,766 
Schedule of Net Sales By Geographical Area
Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates.
Three months ended March 31,
(in thousands)20232022
United States$369,931 $295,126 
EMEA (1)
104,760 112,357 
Japan46,375 45,795 
Korea88,984 85,717 
Rest of World76,240 67,092 
Total net sales$686,290 $606,087 
_______________________________________________________________________________
(1) Europe, the Middle East and Africa ("EMEA")
v3.23.1
Commitments and Contingencies (Tables)
3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Purchase Obligations
The Company's purchase obligations as of March 31, 2023 were as follows:
 Payments Due by Period
 Remainder of     
(in thousands)20232024202520262027Thereafter
Purchase obligations (1)
$245,899 $27,389 $7,133 $2,722 $2,430 $9,653 
_______________________________________________________________________________
(1)    The reported amounts exclude those liabilities included on the unaudited condensed consolidated balance sheet as of March 31, 2023.
v3.23.1
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Variable Interest Entity [Line Items]      
Loan to minority shareholders included in temporary equity $ 4,400,000   $ 4,400,000
Restricted cash 1,800,000   1,800,000
Transaction losses included in selling, general and administrative expenses $ 1,300,000 $ 1,800,000  
VIE      
Variable Interest Entity [Line Items]      
Ownership percentage 40.00%    
Outstanding borrowings $ 0   $ 0
v3.23.1
Allowance for Doubtful Accounts (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Accounts Receivable, Allowance for Credit Loss [Roll Forward]    
Balance at beginning of period $ 8,258 $ 5,980
Bad debt expense 254 922
Amount of receivables written off (52) (44)
Foreign currency translation 48 (72)
Balance at end of period $ 8,508 $ 6,786
v3.23.1
Inventories (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials and supplies $ 150,635 $ 154,881
Work-in-process 28,862 29,689
Finished goods 459,626 490,114
Inventories $ 639,123 $ 674,684
v3.23.1
Product Warranty (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Activity for accrued warranty expense    
Balance at beginning of period $ 3,951 $ 4,177
Provision 1,675 995
Claims paid/costs incurred (1,229) (1,045)
Foreign currency translation (11) (36)
Balance at end of period $ 4,386 $ 4,091
Minimum    
Product Warranty Liability [Line Items]    
Product warranty period 1 year  
Maximum    
Product Warranty Liability [Line Items]    
Product warranty period 2 years  
v3.23.1
Debt and Financing Arrangements (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Aug. 02, 2022
Aug. 01, 2022
Unsecured Local Credit Facilities        
Line of Credit Facility [Line Items]        
Weighted average interest rate (as percent) 0.82% 0.85%    
Available borrowings $ 25,300,000      
Other short-term borrowings, outstanding borrowings 44,600,000 $ 40,300,000    
Secured Debt        
Line of Credit Facility [Line Items]        
Amount outstanding       $ 306,300,000
Revolving Credit Facility        
Line of Credit Facility [Line Items]        
Maximum borrowing capacity     $ 950,000,000  
Outstanding borrowings $ 783,000,000     $ 72,600,000
Weighted average interest rate (as percent) 5.87%      
Available borrowings $ 158,800,000      
Letters of credit outstanding 8,200,000      
Letters of Credit        
Line of Credit Facility [Line Items]        
Maximum borrowing capacity 58,800,000      
Outstanding borrowings 12,000,000 10,000,000    
Line of credit secured $ 8,600,000 $ 7,300,000    
v3.23.1
Derivative Financial Instruments - Narrative (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Derivatives, Fair Value [Line Items]      
Transaction gain (losses) included in selling, general and administrative expenses $ (1,300,000) $ (1,800,000)  
Not Designated As Hedging Instrument      
Derivatives, Fair Value [Line Items]      
Transaction gain (losses) included in selling, general and administrative expenses 100,000 $ 300,000  
Foreign exchange forward      
Derivatives, Fair Value [Line Items]      
Expected reclassification of net gain recorded in accumulated other comprehensive loss, net of tax into cost of goods sold during next twelve months 2,400,000    
Foreign exchange forward | Derivative Designated As Hedging      
Derivatives, Fair Value [Line Items]      
Notional amount 225,300,000   $ 242,400,000
Foreign exchange forward | Not Designated As Hedging Instrument      
Derivatives, Fair Value [Line Items]      
Notional amount $ 4,000,000   4,000,000
Foreign exchange forward | Maximum      
Derivatives, Fair Value [Line Items]      
Term of derivative contract (in months) 24 months    
Interest rate swap | Derivative Designated As Hedging      
Derivatives, Fair Value [Line Items]      
Notional amount $ 100,000,000   $ 0
v3.23.1
Derivative Financial Instruments - Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets (Details) - Derivative Designated As Hedging - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Foreign exchange forward | Prepaid and other assets    
Derivatives, Fair Value [Line Items]    
Asset derivatives $ 6,078 $ 7,393
Foreign exchange forward | Other assets    
Derivatives, Fair Value [Line Items]    
Asset derivatives 87 1,341
Foreign exchange forward | Accrued expenses and other liabilities    
Derivatives, Fair Value [Line Items]    
Liability derivatives 3,817 4,710
Foreign exchange forward | Other noncurrent liabilities    
Derivatives, Fair Value [Line Items]    
Liability derivatives 505 344
Interest rate swap | Prepaid and other assets    
Derivatives, Fair Value [Line Items]    
Asset derivatives 344 0
Interest rate swap | Accrued expenses and other liabilities    
Derivatives, Fair Value [Line Items]    
Liability derivatives 17 0
Interest rate swap | Other noncurrent liabilities    
Derivatives, Fair Value [Line Items]    
Liability derivatives $ 699 $ 0
v3.23.1
Derivative Financial Instruments - Schedule of Effect of Hedge Instruments on Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized in accumulated other comprehensive loss, net of tax $ (833) $ 3,076
Cash Flow Hedge | Derivative Designated As Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized in accumulated other comprehensive loss, net of tax (833) 3,076
Foreign exchange forward | Cash Flow Hedge | Derivative Designated As Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized in accumulated other comprehensive loss, net of tax (477) 3,076
Interest rate swap | Cash Flow Hedge | Derivative Designated As Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized in accumulated other comprehensive loss, net of tax $ (356) $ 0
v3.23.1
Derivative Financial Instruments - Schedule of Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations (Details) - Derivative Designated As Hedging - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Foreign exchange forward    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain (loss) recognized on unaudited condensed consolidated statements of operations $ 5,406 $ 2,030
Foreign exchange forward | Cost of goods sold    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of goods sold Cost of goods sold
Gain (loss) recognized on unaudited condensed consolidated statements of operations $ 5,196 $ 1,355
Foreign exchange forward | Selling, general and administrative    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Selling, general and administrative Selling, general and administrative
Gain (loss) recognized on unaudited condensed consolidated statements of operations $ 210 $ 675
Interest rate swap    
Derivative Instruments, Gain (Loss) [Line Items]    
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Interest expense, net Interest expense, net
Gain (loss) recognized on unaudited condensed consolidated statements of operations $ 15 $ 0
v3.23.1
Fair Value Measurements (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Level 1    
Assets    
Rabbi trust $ 4,135 $ 3,940
Deferred compensation program assets 670 631
Total assets 4,805 4,571
Liabilities    
Deferred compensation program liabilities 670 631
Total liabilities 670 631
Level 1 | Foreign exchange derivative instruments    
Assets    
Foreign exchange derivative instruments 0 0
Foreign exchange derivative instruments 0 0
Liabilities    
Derivative instruments, current 0 0
Derivative instruments, noncurrent 0 0
Level 1 | Interest rate derivative instruments    
Assets    
Interest rate derivative instruments 0  
Liabilities    
Derivative instruments, current 0  
Derivative instruments, noncurrent 0  
Level 2    
Assets    
Rabbi trust 0 0
Deferred compensation program assets 0 0
Total assets 6,529 8,734
Liabilities    
Deferred compensation program liabilities 0 0
Total liabilities 5,038 5,102
Level 2 | Foreign exchange derivative instruments    
Assets    
Foreign exchange derivative instruments 6,098 7,393
Foreign exchange derivative instruments 87 1,341
Liabilities    
Derivative instruments, current 3,817 4,758
Derivative instruments, noncurrent 505 344
Level 2 | Interest rate derivative instruments    
Assets    
Interest rate derivative instruments 344  
Liabilities    
Derivative instruments, current 17  
Derivative instruments, noncurrent 699  
Level 3    
Assets    
Rabbi trust 0 0
Deferred compensation program assets 0 0
Total assets 0 0
Liabilities    
Deferred compensation program liabilities 0 0
Total liabilities 0 0
Level 3 | Foreign exchange derivative instruments    
Assets    
Foreign exchange derivative instruments 0 0
Foreign exchange derivative instruments 0 0
Liabilities    
Derivative instruments, current 0 0
Derivative instruments, noncurrent 0 $ 0
Level 3 | Interest rate derivative instruments    
Assets    
Interest rate derivative instruments 0  
Liabilities    
Derivative instruments, current 0  
Derivative instruments, noncurrent $ 0  
v3.23.1
Pension and Other Postretirement Benefits (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Pension Benefits    
Components of net periodic benefit cost    
Service cost $ 1,434 $ 2,007
Interest cost 2,943 2,234
Expected return on plan assets (1,962) (1,871)
Amortization of net loss (gain) 21 935
Amortization of prior service cost (credit) 46 69
Net periodic benefit cost 2,482 3,374
Postretirement Benefits    
Components of net periodic benefit cost    
Service cost 119 160
Interest cost 172 84
Expected return on plan assets 0 0
Amortization of net loss (gain) (201) (152)
Amortization of prior service cost (credit) (34) (34)
Net periodic benefit cost $ 56 $ 58
v3.23.1
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Tax Disclosure [Abstract]    
Decrease in income tax expense $ 200  
Income tax expense (benefit) $ 20,725 $ 20,919
Effective tax rate (as percent) 18.10% 20.40%
v3.23.1
Common Stock - Schedule of Declared Dividends Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2022
Equity [Abstract]            
Dividends per Common Share (in dollars per share) $ 0.195 $ 0.180 $ 0.180 $ 0.180 $ 0.180 $ 0.720
Amount $ 13,629 $ 12,986 $ 13,192 $ 13,400 $ 13,473 $ 53,051
v3.23.1
Common Stock - Narrative (Details) - USD ($)
3 Months Ended
Jan. 23, 2023
Jan. 13, 2023
Jan. 24, 2022
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Dec. 31, 2022
Aug. 30, 2022
Jun. 16, 2022
Nov. 08, 2021
Dividends Payable [Line Items]                    
Issued and outstanding common stock authorized to repurchase       $ 700,000,000            
Shares repurchased (in shares)       2,514,917 1,163,799          
Aggregate value       $ 116,123,000 $ 59,108,000          
Accrued share repurchase (in shares)             2,000,839      
Amount remaining under current authorizations       $ 291,300,000            
Magnus                    
Dividends Payable [Line Items]                    
Issued and outstanding common stock authorized to repurchase               $ 100,000,000 $ 75,000,000  
Stock repurchase program, authorized amount                   $ 37,500,000
Shares repurchased (in shares) 2,168,528   699,819 2,168,528 699,819          
Aggregate value $ 100,000,000   $ 37,500,000 $ 100,001,000 $ 37,501,000          
Share repurchase liability       $ 92,600,000            
Accrued share repurchase (in shares)       2,000,839            
Open Market                    
Dividends Payable [Line Items]                    
Shares repurchased (in shares)   167,689   346,389 463,980          
Aggregate value   $ 7,400,000   $ 16,122,000 $ 21,607,000          
Aggregate purchases of shares in open market before shares will be purchased from Magnus       $ 100,000,000            
Forecast                    
Dividends Payable [Line Items]                    
Dividends declared and payable (in dollars per share)           $ 0.195        
v3.23.1
Common Stock - Schedule of Share Repurchase Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jan. 23, 2023
Jan. 13, 2023
Jan. 24, 2022
Mar. 31, 2023
Mar. 31, 2022
Dividends Payable [Line Items]          
Shares repurchased (in shares)       2,514,917 1,163,799
Average price (in dollars per share)       $ 46.17 $ 50.79
Aggregate value       $ 116,123 $ 59,108
Open Market          
Dividends Payable [Line Items]          
Shares repurchased (in shares)   167,689   346,389 463,980
Average price (in dollars per share)       $ 46.54 $ 46.57
Aggregate value   $ 7,400   $ 16,122 $ 21,607
Magnus          
Dividends Payable [Line Items]          
Shares repurchased (in shares) 2,168,528   699,819 2,168,528 699,819
Average price (in dollars per share)       $ 46.11 $ 53.59
Aggregate value $ 100,000   $ 37,500 $ 100,001 $ 37,501
v3.23.1
Equity Incentive Plans - Narrative (Details)
$ in Millions
3 Months Ended
Mar. 31, 2023
USD ($)
RSUs | 2015 Omnibus Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation expense $ 27.7
Weighted average period (in years) 1 year 7 months 6 days
RSUs | Company Officers  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting period (in years) 3 years
Vesting percentage 33.33%
RSUs | Officers, Employees, Consultants and Advisors  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting period (in years) 3 years
RSUs | Other Employees  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting percentage 33.33%
PSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting period (in years) 3 years
PSUs | 2015 Omnibus Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation expense $ 15.0
Weighted average period (in years) 2 years 2 months 12 days
PSUs | Minimum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting percentage 0.00%
PSUs | Maximum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting percentage 200.00%
v3.23.1
Equity Incentive Plans - Schedule of Restricted and Performance Stock Units (Details) - 2015 Omnibus Incentive Plan
3 Months Ended
Mar. 31, 2023
$ / shares
shares
Common Stock  
Weighted - Average Fair Value  
Undelivered (in shares) 460,684
RSUs  
Number of Units  
Outstanding at beginning of the period (in shares) 944,695
Granted (in shares) 337,567
Vested (in shares) (499,896)
Forfeited (in shares) (4,179)
Outstanding at end of the period (in shares) 778,187
Weighted - Average Fair Value  
Outstanding at beginning of the period (in dollars per share) | $ / shares $ 37.48
Granted (in dollars per share) | $ / shares 48.58
Vested (in dollars per share) | $ / shares 31.04
Forfeited (in dollars per share) | $ / shares 43.87
Outstanding at end of the period (in dollars per share) | $ / shares $ 46.40
Undelivered (in shares) 75,157
PSUs  
Number of Units  
Outstanding at beginning of the period (in shares) 529,366
Granted (in shares) 168,251
Vested (in shares) (231,127)
Forfeited (in shares) (12,377)
Outstanding at end of the period (in shares) 454,113
Weighted - Average Fair Value  
Outstanding at beginning of the period (in dollars per share) | $ / shares $ 36.30
Granted (in dollars per share) | $ / shares 48.58
Vested (in dollars per share) | $ / shares 25.73
Forfeited (in dollars per share) | $ / shares 41.78
Outstanding at end of the period (in dollars per share) | $ / shares $ 46.08
Undelivered (in shares) 229,205
v3.23.1
Equity Incentive Plans - Schedule of Compensation Expense Recorded in the Consolidated Statement of Operations (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense $ 7,283 $ 5,353
RSUs | 2015 Omnibus Incentive Plan    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense 4,154 2,770
PSUs | 2015 Omnibus Incentive Plan    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense $ 2,965 $ 2,419
v3.23.1
Equity Incentive Plans - Schedule of Shares of Common Stock Issued (Details) - 2015 Omnibus Incentive Plan - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
RSUs    
Class of Stock [Line Items]    
Cumulative undelivered shares of common stock (in shares) 75,157  
PSUs    
Class of Stock [Line Items]    
Cumulative undelivered shares of common stock (in shares) 229,205  
Common Stock | RSUs    
Class of Stock [Line Items]    
Shares of common stock issued (in shares) 436,491 492,580
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares) (128,291) (159,851)
Net shares of common stock issued (in shares) 308,200 332,729
Cumulative undelivered shares of common stock (in shares) 471,306 414,866
Common Stock | PSUs    
Class of Stock [Line Items]    
Shares of common stock issued (in shares) 231,580 188,527
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares) (91,842) (87,215)
Net shares of common stock issued (in shares) 139,738 101,312
Cumulative undelivered shares of common stock (in shares) 420,447 191,242
v3.23.1
Equity Incentive Plans - Schedule of Compensation Expense Related to Equity Incentive Plans (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax $ 7,283 $ 5,353
Income tax benefit 1,492 1,176
Total compensation expense, net of income tax 5,791 4,177
Cost of goods sold    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax 373 300
Selling, general and administrative    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax 6,223 4,698
Research and development    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax $ 687 $ 355
v3.23.1
Accumulated Other Comprehensive Loss, Net of Tax (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Beginning balance $ 976,703
Other comprehensive (loss) income before reclassifications (506)
Amounts reclassified from accumulated other comprehensive loss, net of tax (5,379)
Tax expense 1,874
Ending balance 1,025,148
Foreign Currency Translation  
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Beginning balance (97,855)
Other comprehensive (loss) income before reclassifications 565
Amounts reclassified from accumulated other comprehensive loss, net of tax 0
Tax expense 0
Ending balance (97,290)
Gains (Losses) on Derivative Instruments | Foreign Exchange Derivative Instruments  
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Beginning balance 5,598
Other comprehensive (loss) income before reclassifications (477)
Amounts reclassified from accumulated other comprehensive loss, net of tax (5,196)
Tax expense 1,694
Ending balance 1,619
Gains (Losses) on Derivative Instruments | Interest rate swap  
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Beginning balance 0
Other comprehensive (loss) income before reclassifications (356)
Amounts reclassified from accumulated other comprehensive loss, net of tax (15)
Tax expense 90
Ending balance (281)
Pension and Other Postretirement  
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Beginning balance (17,411)
Other comprehensive (loss) income before reclassifications (238)
Amounts reclassified from accumulated other comprehensive loss, net of tax (168)
Tax expense 90
Ending balance (17,727)
Accumulated Other Comprehensive Loss, Net of Tax  
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Beginning balance (109,668)
Ending balance $ (113,679)
v3.23.1
Net Income per Common Share - Schedule of Computation of Basic and Diluted Net Income Per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Net income attributable to Acushnet Holdings Corp. $ 93,275 $ 81,045
Weighted average number of common shares:    
Basic (in shares) 68,213,068 73,513,109
Diluted (in shares) 68,646,212 73,922,728
Net income per common share attributable to Acushnet Holdings Corp.:    
Basic (in dollars per share) $ 1.37 $ 1.10
Diluted (in dollars per share) $ 1.36 $ 1.10
RSUs    
Weighted average number of common shares:    
Basic (in shares) 340,101 325,550
PSUs    
Weighted average number of common shares:    
Basic (in shares) 93,043 84,069
v3.23.1
Net Income per Common Share - Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares (Details) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
RSUs    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Securities excluded from calculation of diluted weighted-average common shares outstanding as their impact was anti-dilutive (in shares) 259,496 66,405
v3.23.1
Segment Information - Schedule of Information by Reportable Segment and a Reconciliation to Reported Amounts (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
segment
Mar. 31, 2022
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 4  
Segment Reporting Information [Line Items]    
Net sales $ 686,290 $ 606,087
Segment operating income 124,904 105,369
Reconciling items:    
Interest expense, net (9,896) (1,277)
Income before income taxes 114,344 102,766
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 686,290 606,087
Segment operating income 128,721 106,537
Reconciling Items    
Reconciling items:    
Interest expense, net (9,896) (1,277)
Non-service cost component of net periodic benefit cost (985) (1,265)
Other (3,496) (1,229)
Titleist golf balls | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 192,001 163,838
Segment operating income 38,621 33,373
Titleist golf clubs | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 180,781 160,815
Segment operating income 40,545 32,228
Titleist golf gear | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 67,043 44,146
Segment operating income 12,190 2,194
FootJoy golf wear | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 205,274 197,553
Segment operating income 30,801 31,315
Other | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 41,191 39,735
Segment operating income $ 6,564 $ 7,427
v3.23.1
Segment Information - Schedule of Net Sales By Geographical Area (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales $ 686,290 $ 606,087
United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 369,931 295,126
EMEA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 104,760 112,357
Japan    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 46,375 45,795
Korea    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 88,984 85,717
Rest of World    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales $ 76,240 $ 67,092
v3.23.1
Commitments and Contingencies (Details)
$ in Thousands
Mar. 31, 2023
USD ($)
Payments Due by Period  
Remainder of 2023 $ 245,899
2024 27,389
2025 7,133
2026 2,722
2027 2,430
Thereafter $ 9,653
v3.23.1
Other Business Developments (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended
Jan. 03, 2023
Nov. 04, 2022
Apr. 01, 2022
Jan. 31, 2023
Mar. 31, 2023
Mar. 31, 2022
Business Acquisition [Line Items]            
Payments to acquire intangible assets         $ 22,235 $ 0
Contingent consideration (Note 16)         $ 3,000 $ 0
TPI            
Business Acquisition [Line Items]            
Cash consideration   $ 18,400        
Percent of certain assets and liabilities acquired   80.00%        
Redeemable noncontrolling interest   $ 4,600        
PG Golf LLC            
Business Acquisition [Line Items]            
Cash consideration     $ 3,600      
Consideration transferred     5,000      
Contingent consideration (Note 16)     $ 1,400      
Trademarks, Domains and Products | Club Glove            
Business Acquisition [Line Items]            
Payments to acquire intangible assets       $ 25,200    
Cash consideration       22,200    
Asset acquisition, contingent consideration       $ 3,000    
Weighted average useful life 10 years